PROCTER & GAMBLE HEALTH | WYETH | PROCTER & GAMBLE HEALTH/ WYETH |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.6 | 27.7 | 124.7% | View Chart |
P/BV | x | 10.5 | 11.3 | 93.6% | View Chart |
Dividend Yield | % | 2.0 | 10.9 | 18.5% |
PROCTER & GAMBLE HEALTH WYETH |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
WYETH Mar-14 |
PROCTER & GAMBLE HEALTH/ WYETH |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 1,065 | 503.8% | |
Low | Rs | 3,883 | 553 | 702.1% | |
Sales per share (Unadj.) | Rs | 740.7 | 289.5 | 255.9% | |
Earnings per share (Unadj.) | Rs | 138.2 | 38.7 | 357.2% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 39.9 | 388.9% | |
Dividends per share (Unadj.) | Rs | 95.00 | 145.00 | 65.5% | |
Avg Dividend yield | % | 2.1 | 17.9 | 11.5% | |
Book value per share (Unadj.) | Rs | 447.6 | 118.5 | 377.7% | |
Shares outstanding (eoy) | m | 16.60 | 22.72 | 73.1% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 2.8 | 223.4% | |
Avg P/E ratio | x | 33.5 | 20.9 | 160.0% | |
P/CF ratio (eoy) | x | 29.8 | 20.3 | 147.0% | |
Price / Book Value ratio | x | 10.3 | 6.8 | 151.3% | |
Dividend payout | % | 68.7 | 374.7 | 18.3% | |
Avg Mkt Cap | Rs m | 76,761 | 18,381 | 417.6% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 359 | 575.1% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 6,577 | 187.0% | |
Other income | Rs m | 184 | 347 | 52.9% | |
Total revenues | Rs m | 12,480 | 6,925 | 180.2% | |
Gross profit | Rs m | 3,247 | 1,023 | 317.3% | |
Depreciation | Rs m | 281 | 27 | 1,026.3% | |
Interest | Rs m | 8 | 4 | 175.4% | |
Profit before tax | Rs m | 3,142 | 1,339 | 234.7% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 460 | 184.3% | |
Profit after tax | Rs m | 2,295 | 879 | 261.0% | |
Gross profit margin | % | 26.4 | 15.6 | 169.7% | |
Effective tax rate | % | 27.0 | 34.3 | 78.6% | |
Net profit margin | % | 18.7 | 13.4 | 139.6% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 3,964 | 295.5% | |
Current liabilities | Rs m | 6,791 | 2,081 | 326.3% | |
Net working cap to sales | % | 40.0 | 28.6 | 139.8% | |
Current ratio | x | 1.7 | 1.9 | 90.6% | |
Inventory Days | Days | 263 | 35 | 748.8% | |
Debtors Days | Days | 343 | 278 | 123.7% | |
Net fixed assets | Rs m | 10,617 | 878 | 1,209.4% | |
Share capital | Rs m | 166 | 227 | 73.1% | |
"Free" reserves | Rs m | 7,265 | 2,466 | 294.6% | |
Net worth | Rs m | 7,431 | 2,693 | 275.9% | |
Long term debt | Rs m | 0 | 25 | 0.0% | |
Total assets | Rs m | 22,330 | 4,842 | 461.2% | |
Interest coverage | x | 409.1 | 306.0 | 133.7% | |
Debt to equity ratio | x | 0 | 0 | 0.0% | |
Sales to assets ratio | x | 0.6 | 1.4 | 40.5% | |
Return on assets | % | 10.3 | 18.2 | 56.5% | |
Return on equity | % | 30.9 | 32.6 | 94.6% | |
Return on capital | % | 42.4 | 49.4 | 85.8% | |
Exports to sales | % | 0 | 0.1 | 0.0% | |
Imports to sales | % | 13.1 | 34.7 | 37.6% | |
Exports (fob) | Rs m | NA | 8 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 2,281 | 70.4% | |
Fx inflow | Rs m | 1,465 | 8 | 19,253.6% | |
Fx outflow | Rs m | 1,605 | 2,298 | 69.9% | |
Net fx | Rs m | -140 | -2,291 | 6.1% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 1,188 | 198.6% | |
From Investments | Rs m | -215 | 287 | -74.9% | |
From Financial Activity | Rs m | -985 | -4,296 | 22.9% | |
Net Cashflow | Rs m | 1,160 | -2,821 | -41.1% |
Indian Promoters | % | 0.0 | 0.0 | - | |
Foreign collaborators | % | 51.8 | 51.1 | 101.4% | |
Indian inst/Mut Fund | % | 20.0 | 18.4 | 108.7% | |
FIIs | % | 6.2 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 48.9 | 98.6% | |
Shareholders | 56,778 | 25,706 | 220.9% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES SUN PHARMA CIPLA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | WYETH | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.79% | -2.27% | 0.35% |
1-Month | -3.50% | 18.58% | 2.33% |
1-Year | -0.37% | 69.59% | 54.34% |
3-Year CAGR | -9.39% | 15.36% | 15.02% |
5-Year CAGR | 3.91% | 8.95% | 19.24% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the WYETH share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of WYETH the stake stands at 51.1%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of WYETH.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
WYETH paid Rs 145.0, and its dividend payout ratio stood at 374.7%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of WYETH.
For a sector overview, read our pharmaceuticals sector report.
Indian share markets Slipped further as the session progressed and ended the day weak.